CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Decitabine Dose-Tolerance in Surgically Resectable HPV-Negative Head and Neck Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06997094
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:34.407600+00:00
Published At: 2026-01-26T00:00:00+00:00
Record Updated At: 2026-01-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Human Papillomavirus-Negative Neck Squamous Cell Carcinoma", "Resectable Head and Neck Squamous Cell Carcinoma", "Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma", "HPV-Negative Squamous Cell Carcinoma", "Resectable Head and Neck Squamous-cell Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-01-26"
protocolSection.identificationModule.nctId: "NCT06997094"
protocolSection.identificationModule.officialTitle: "Phase I Decitabine Dose-Tolerance in Surgically Resectable HPV-Negative Head and Neck Cancer"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.